Determination of the prevalence of antimicrobial resistance to macrolide antimicrobials or rifampin in Rhodococcus equi isolates and treatment outcome in foals infected with antimicrobial-resistant isolates of R equi

Journal of the American Veterinary Medical Association

Volumn 237, Issue 1, 2010, Pages 74-81

  Giguère, Steeve ^a   Lee, Elise ^b   Williams, Elliott ^b   Cohen, Noah D ^c   Chaffin, M Keith ^c   Haibert, Natalie ^c   Martens, Ronald J ^c   Franklin, Robert P ^d   Clark, Carol C ^e   Slovis, Nathan M ^f  

^a UNIVERSITY OF GEORGIA   (United States)

^b University of Florida College of Veterinary Medicine   (United States)

^c TEXAS A AND M UNIVERSITY   (United States)

^d Weatherford Equine Medical Center   (United States)

^e Peterson and Smith Equine Hospital   (United States)

^f HAGYARD EQUINE MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; MACROLIDE; RIFAMPICIN;

ACTINOMYCETALES INFECTION; ANIMAL; ANIMAL DISEASE; ANTIBIOTIC RESISTANCE; ARTICLE; DRUG EFFECT; HORSE; HORSE DISEASE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PATHOGENICITY; RHODOCOCCUS EQUI; TREATMENT OUTCOME; VIRULENCE;

ACTINOMYCETALES INFECTIONS; ANIMALS; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; HORSE DISEASES; HORSES; MACROLIDES; MICROBIAL SENSITIVITY TESTS; RHODOCOCCUS EQUI; RIFAMPIN; TREATMENT OUTCOME; VIRULENCE;

RHODOCOCCUS EQUI;

EID: 77954256294     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.237.1.74     Document Type: Article

References (41)

1. Giguère S, Prescott JE Clinical manifestations, diagnosis, treatment, and prevention of Rhodococcus equi infections in foals. Vet Microbiol 1997; 56: 313-334. (Pubitemid 27339160)
2. Reuss SM, Chaffin MK, Cohen ND. Extrapulmonary disorders associated with Rhodococcus equi infection in foals: a retrospective study of 150 cases (1987-2007). Proc Am Assoc Equine Pract 2008; 54: 528.
3. Arlotti M, Zoboli G, Moscatelli GL, et al. Rhodococcus equi infection in HIV-positive subjects: a retrospective analysis of 24 cases. Scand J Infect Dis 1996; 28: 463-467. (Pubitemid 26393588)
4. Donisi A, Suardi MG, Casari S, et al. Rhodococcus equi infection in HIV-infected patients. AIDS 1996; 10: 359-362.
5. Harvey RL, Sunstrum JC. Rhodococcus equi infection in patients with and without human immunodeficiency virus infection. Rev Infect Dis 1991; 13: 139-145.
6. Takai S, Hines SA, Sekizaki T, et al. DNA Sequence and comparison of virulence plasmids from Rhodococcus equi ATCC 33701 and 103. Infect Immun 2000; 68: 6840-6847. (Pubitemid 32463392)
7. Giguère S, Hondalus MK, Yager JA, et al. Role of the 85-kilobase plasmid and plasmid-encoded virulence-associated protein A in intracellular survival and virulence of Rhodococcus equi. Infect Immun 1999; 67: 3548-3557. (Pubitemid 29291528)
8. Wada R, Kamada M, Anzai T, et al. Pathogenicity and virulence of Rhodococcus equi in foals following intratracheal challenge. Vet Microbiol 1997; 56: 301-312.
9. Prescott JE The susceptibility of isolates of Corynebacterium equi to antimicrobial drugs. J Vet Pharmacol Ther 1981; 4: 27-31.
10. Jacks SS, Giguère S, Nguyen A. In vitro susceptibilities of Rhodococcus equi and other common equine pathogens to azithromycin, clarithromycin, and 20 other antimicrobials. Antimicrob Agents Chemother 2003; 47: 1742-1745. (Pubitemid 36548565)
11. Sweeney CR, Sweeney RW, Divers TJ. Rhodococcus equi pneumonia in 48 foals: response to antimicrobial therapy. Vet Microbiol 1987; 14: 329-336.
12. Hillidge CJ. Use of erythromycin-rifampin combination in treatment of Rhodococcus equi pneumonia. Vet Microbiol 1987; 14: 337-342.
13. Giguère S, Jacks S, Roberts GD, et al. Retrospective comparison of azithromycin, clarithromycin, and erythromycin for the treatment of foals with Rhodococcus equi pneumonia. J Vet Intern Med 2004; 18: 568-573.
14. Fines M, Pronost S, Maillard K, et al. Characterization of mutations in the rpoB gene associated with rifampin resistance in Rhodococcus equi isolated from foals. J Clin Microbiol 2001; 39: 2784-2787.
15. Kenney DG, Robbins SC, Prescott JF, et al. Development of reactive arthritis and resistance to erythromycin and rifampin in a foal during treatment for Rhodococcus equi pneumonia. Equine Vet J 1994; 26: 246-248.
16. Takai S, Takeda K, Nakano Y, et al. Emergence of rifampinresistant Rhodococcus equi in an infected foal. J Clin Microbiol 1997; 35: 1904-1908.
17. CLSI. Performance standards for antimicrobial dis and dilution susceptibility tests for bacteria isolated from animals; a. CLSI document M31-A3. Wayne, Pa: CLSI, 2008.
18. CLSI. Performance standards for antimicrobial susceptibility testing. CLSI document M100-S19. Wayne, Pa: CLSI, 2009.
19. Chan ED, Iseman MD. Multidrug-resistant and extensively drug-resistant tuberculosis: a review. Curr Opin Infect Dis 2008; 21: 587-595.
20. Zignol M, Hosseini MS, Wright A, et al. Global incidence of multidrug-resistant tuberculosis. J Infect Dis 2006; 194: 479-485.
21. Hsueh PR, Hung CC, Teng LJ, et al. Report of invasive Rhodococcus equi infections in Taiwan, with an emphasis on the emergence of multidrug-resistant strains. Clin Infect Dis 1998; 27: 370-375.
22. McNeil MM, Brown JM. Distribution and antimicrobial susceptibility of Rhodococcus equi from clinical specimens. Eur J Epidemiol 1992; 8: 437-443.
23. Nordmann P, Ronco E. In-vitro antimicrobial susceptibility of Rhodococcus equi. J Antimicrob Chemother 1992; 29: 383-393.
24. Roberts MC. Resistance to macrolide, lincosamide, streptogramin, ketolide, and oxazolidinone antibiotics. Mol Biotechnol 2004; 28: 47-62.
25. Schito GC, Debbia EA, Pesce A. Susceptibility of respiratory strains of Staphylococcus aureus to fifteen antibiotics: results of a collaborative surveillance study (1992-1993). The Alexander Project Collaborative Group. J Antimicrob Chemother 1996; 38(suppl A): 97-106.
26. Barrett MS, Jones RN. Antimicrobial activity and spectrum of Sparfloxacin tested against erythromycin-resistant Streptococcus pneumoniae isolates. Diagn Microbiol Infect Dis 1996; 24: 113-116.
27. Morton AC, Begg AP, Anderson GA, et al. Epidemiology of Rhodococcus equi strains on Thoroughbred horse farms. Appl Environ Microbiol 2001; 67: 2167-2175.
28. Cohen ND, Carter CN, Scott HM, et al. Association of soil concentrations of Rhodococcus equi and incidence of pneumonia attributable to Rhodococcus equi in foals on farms in central Kentucky. Am J Vet Res 2008; 69: 385-395.
29. Takai S, Anzai T, Yamaguchi K, et al. Prevalence of virulence plasmids in environmental isolates of Rhodococcus equi from horse-breeding farms in Hokkaido. J Equine Sci 1994; 5: 21-25.
30. Shah NS, Pratt R, Armstrong L, et al. Extensively drug-resistant tuberculosis in the United States, 1993-2007. JAMA 2008; 300: 2153-2160.
31. Mak A, Thomas A, Del Granado M, et al. Influence of multidrug resistance on tuberculosis treatment outcomes with standardized regimens. Am J Respir Crit Care Med 2008; 178: 306-312.
32. Lew W, Pai M, Oxlade O, et al. Initial drug resistance and tuberculosis treatment outcomes: systematic review and meta-analysis. Ann Intern Med 2008; 149: 123-134.
33. Dowling PM, Wilson RC, Tyler JW, et al. Pharmacokinetics of ciprofloxacin in ponies. J Vet Pharmacol Ther 1995; 18: 7-12.
34. Vivrette S, Bostian A, Bermingham E, et al. Quinolone induced arthropathy in neonatal foals, in Proceedings. 47th Annu Conv Am Assoc Equine Pract 2001; 47: 376-377.
35. Womble AY, Giguère S, Lee EA, et al. Pharmacokinetics of clarithromycin and concentrations in body fluids and bronchoalveolar cells of foals. Am J Vet Res 2006; 67: 1681-1686.
36. Maglio D, Capitano B, Banevicius MA, et al. Differential efficacy of clarithromycin in lung versus thigh infection models. Chemotherapy 2004; 50: 63-66.
37. Weese JS. Prudent use of antimicrobials. In: Giguère S, Prescot JF, Baggot DJ, et al, eds. Antimicrobial therapy in veterinary medicine. 4th ed. Ames, Iowa: Blackwell Publishing, 2006: 437-446.
38. Giguère S, Hernandez J, GaskinJM, et al. Evaluation of white blood cell concentration, plasma fibrinogen concentration, and an agar gel immunodiffusion test for early identification of foals with Rhodococcus equi pneumonia (Erratum published inj Am Vet Med Assoc 2003; 223: 1300) J Am Vet Med Assoc 2003; 222: 775-781.
39. Slovis NM, McCracken JL, Mundy G. How to use thoracic ultrasound to screen foals for Rhodococcus equi at affected farms, in Proceedings. 51st Annu Conv Am Assoc Equine Pract 2005; 51: 274-278.
40. Chaffin MK, Cohen ND, Martens RJ. Chemoprophylactic effects of azithromycin against Rhodococcus equi-induced pneumonia among foals at equine breeding farms with endemic infections. J Am Vet Med Assoc 2008; 232: 1035-1047.
41. Venner M, Reinhold B, Beyerbach M, et al. Efficacy of azithromycin in preventing pulmonary abscesses in foals. Vet J 2007; 179: 301-303.